Avrupa Birliği - İzlandaca - EMA (European Medicines Agency)

mylan pharmaceuticals limited - teriflunomide - heila-og mænusigg, köstum tilkynnt - Ónæmisbælandi lyf - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).

İzlanda - İzlandaca - LYFJASTOFNUN (Icelandic Medicines Agency)

exeltis healthcare s.l. - drospirenonum inn; ethinylestradiolum inn - filmuhúðuð tafla - 3 mg/ 0,03 mg

İzlanda - İzlandaca - LYFJASTOFNUN (Icelandic Medicines Agency)

bayer ab* - levonorgestrelum inn; ethinylestradiolum inn - tafla

İzlanda - İzlandaca - LYFJASTOFNUN (Icelandic Medicines Agency)

csl behring gmbh* - c1-hemill - stungulyfs-/innrennslisstofn og leysir, lausn - 500 a.e.

İzlanda - İzlandaca - LYFJASTOFNUN (Icelandic Medicines Agency)

pfizer aps (p) - gestodenum inn; ethinylestradiolum inn - tafla - 75 míkróg+ 20 míkróg

İzlanda - İzlandaca - LYFJASTOFNUN (Icelandic Medicines Agency)

gedeon richter plc.* - levonorgestrelum inn - tafla - 1,5 mg

İzlanda - İzlandaca - LYFJASTOFNUN (Icelandic Medicines Agency)

csl behring gmbh* - human albumin - innrennslislyf, lausn - 200 g/l

İzlanda - İzlandaca - LYFJASTOFNUN (Icelandic Medicines Agency)

csl behring gmbh* - human serum albumin - innrennslislyf, lausn - 50 g/l

İzlanda - İzlandaca - LYFJASTOFNUN (Icelandic Medicines Agency)

bayer animal health gmbh - imidaclopridum inn; flumethrin - lyfjahálsól - 1,25 g / 0,56 g

İzlanda - İzlandaca - LYFJASTOFNUN (Icelandic Medicines Agency)

bayer animal health gmbh - imidaclopridum inn; flumethrin - lyfjahálsól - 4,5 g / 2,03 g